Arich Enterprise Co Ltd (4173) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Arich Enterprise Co Ltd stock TWD 22.70, price TWD 18.10, upside +25.4%, quality 51 out of 100. Rating: undervalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range 15.58 TWD – 27.40 TWD · fair‑value band 18.33 TWD – 30.55 TWD · the 18.10 TWD price screens below the 22.70 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Follow Arich Enterprise Co in your weekly email
Every Wednesday you see whether Arich Enterprise Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Arich Enterprise Co., Ltd. engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan. It offers sales promotion for pharmaceutical products; warehousing and logistics, and processing services.
Show moreShow less
The company provides distribution and logistics services, including assists manufacturers with bidding processes; inventory management, order processing, invoicing, goods delivery, collection, customer complaint handling, and provides integrated pharmaceutical distribution services.
In addition, it offers activities, such as hospital tender and bidding; pharmaceutical pricing negotiations; cold chain, clinical trial drug, and controlled drugs management; information, and financial flow. Arich Enterprise Co., Ltd. was founded in 1969 and is based in New Taipei City, Taiwan.
Stock analysis
Arich Enterprise Co Ltd (4173) currently trades at 18.10 TWD, while our model-based Fair Value estimate is 22.70 TWD, implying the stock looks roughly 20% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 29.81 TWD per share, and 14 of the 17 models we run sit above the 18.10 TWD price.
Bear case: the Earnings-Based group reads lowest at 16.22 TWD, and 3 of the 17 models stay below the price. Data coverage for this calculation is low.
Scenario range: 18.33 TWD (bear) to 30.55 TWD (bull), the price of 18.10 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Arich Enterprise Co Ltd reported revenue of 1.5B TWD in FY2025 versus 946M TWD in FY2021, a compound +13.1%/yr. Reported net income was 86.8M TWD in FY2025, compounding +11.9%/yr from FY2021.
Key figures
Market cap 1.3B TWD (≈ $41.1M) Micro · P/E ratio 22.6 · P/S ratio 0.86 · EPS (TTM) 0.8000 TWD · Dividend yield 5.7% · Net margin 3.8% · Return on equity 3.1% · Return on assets (EBIT) 1.7% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 29 out of 100 (low confidence).
What moves the price
The share trades about 18% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 24% fair-value upside, at 25%, 4173 screens cheaper than that median.
Fair Value models
Bear18.33 TWDFair Value 22.70 TWDBull30.55 TWD
Price 18.10 TWD · Upside +25.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.35/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+19.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.3%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+15.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+9.5%
Dividend (yield on the price)5.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 7%
⚠ Revenue per share shrinking 5.5%/yr over ~6Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Compare Arich Enterprise Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 50 stocks
Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score51 · Below median
Fair Value upside+25.4% · Above median
Profitability
Return on equity (12 months)3.1% · Below median
Return on assets1.7% · Below median
Net margin (12 months)3.8% · Above median
Operating margin (12 months)4.1% · Above median
Growth and dividend
Revenue growth (quarter YoY)−0.7% · Below median
Dividend yield (12 months)5.7% · Top 25%
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Arich Enterprise Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/4173
Frequently asked questions
Is Arich Enterprise Co Ltd (4173) overvalued or undervalued?
As of Nov 4, 2026, our model estimates a fair value of 22.70 TWD versus a price of 18.10 TWD, about +25% upside (undervalued).
What is the fair value of 4173?
Our model-based fair value for Arich Enterprise Co Ltd is 22.70 TWD (as of Nov 4, 2026), built from audited fundamentals. The current price: 18.10 TWD.
What is the quality score of 4173?
Arich Enterprise Co Ltd has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Arich Enterprise Co Ltd (4173)?
Our model-based price target is the fair value of 22.70 TWD (as of Nov 4, 2026) from 17 valuation models. Cautious scenario 18.33 TWD, optimistic scenario 30.55 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Arich Enterprise Co Ltd stock forecast for 2026?
Our models put fair value at 22.70 TWD, about +25% upside versus a price of 18.10 TWD (undervalued). Cautious scenario 18.33 TWD, optimistic scenario 30.55 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Arich Enterprise Co Ltd (4173)?
Arich Enterprise Co Ltd reported trailing-twelve-month revenue of about 1.6B TWD (latest available figure, as of Nov 4, 2026).
Does Arich Enterprise Co Ltd pay a dividend?
Arich Enterprise Co Ltd currently shows a dividend yield of 5.75% relative to its recent price (as of Nov 4, 2026).
How much is the dividend of Arich Enterprise Co Ltd (4173) and when is the ex-dividend date?
Arich Enterprise Co Ltd pays a dividend of 1.04 TWD per share a year, a dividend yield of 5.7%. The last ex-dividend date was Apr 16, 2026. A dividend has been paid every year since at least 2013. The payout ratio is 130% of earnings. Our assessment: Pays more than it earns. The company pays out more in dividends than it earns, and free cash flow clearly does not cover the dividend either. It may need to be cut unless profits recover.
What is the intrinsic value of Arich Enterprise Co Ltd (4173)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Arich Enterprise Co Ltd it is 22.70 TWD per share (as of Nov 4, 2026), against a price of 18.10 TWD. It is the blended result of 17 valuation models in 7 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Arich Enterprise Co Ltd stock overvalued or undervalued in 2026?
As of Nov 4, 2026, 4173 trades below its calculated fair value: price 18.10 TWD, fair value 22.70 TWD, a gap of about +25% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 4173?
No. The price is what the market pays today (18.10 TWD); the fair value is what the company's own numbers justify (22.70 TWD). For Arich Enterprise Co Ltd the two are 4.60 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Arich Enterprise Co Ltd worth?
The market values Arich Enterprise Co Ltd at about 1.3B TWD (market capitalisation, as of Nov 4, 2026). Per share that is 18.10 TWD; our models calculate a fair value of 22.70 TWD per share.
What do the bullish and bearish scenarios say about 4173?
Our models span a range for Arich Enterprise Co Ltd: cautious scenario 18.33 TWD, base 22.70 TWD, optimistic 30.55 TWD per share (as of Nov 4, 2026, price 18.10 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 4173?
Arich Enterprise Co Ltd trades at a price-to-earnings ratio of 22.6 (as of Nov 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 22.70 TWD is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings: 21.4. Other multiples: P/B 0.7, P/S 0.9, EV/EBITDA 8.2.
How solid is the balance sheet of Arich Enterprise Co Ltd (4173)?
Balance-sheet figures for Arich Enterprise Co Ltd (as of Nov 4, 2026): return on equity 3.1%. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 4173 from its 52-week high?
Arich Enterprise Co Ltd trades at 18.10 TWD, about 18% below its 52-week high of 22.15 TWD and 6% above the low of 17.00 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 22.70 TWD is for.
Which stocks are comparable to Arich Enterprise Co Ltd?
From the same area (Healthcare) we also value JD Health International Inc, Yifeng Pharmacy Chain Co, DaShenLin Pharmaceutical Group, LBX Pharmacy Chain Joint Stock Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Arich Enterprise Co Ltd stock attractive at the current price?
The data as of Nov 4, 2026: price 18.10 TWD, calculated fair value 22.70 TWD (+25%), Quality Score 51/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 4173 calculated?
We run Arich Enterprise Co Ltd through 17 models from 7 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 22.70 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Arich Enterprise Co Ltd currently trades 20% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Arich Enterprise Co Ltd (4173)?
The closing price on Nov 9, 2026 was 18.10 TWD. Our model-based fair value is 22.70 TWD, about +25% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Arich Enterprise Co Ltd right now?
Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Arich Enterprise Co Ltd
How large is the market capitalisation of Arich Enterprise Co Ltd (4173)?
The market capitalisation of Arich Enterprise Co Ltd is 1.3B TWD (≈ $41.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Arich Enterprise Co Ltd (4173)?
The price-to-sales ratio of Arich Enterprise Co Ltd is 0.86 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Arich Enterprise Co Ltd (4173)?
Earnings per share at Arich Enterprise Co Ltd are 0.8000 TWD (price ÷ EPS = P/E 22.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Arich Enterprise Co Ltd (4173)?
The dividend yield of Arich Enterprise Co Ltd is 5.7% (payout 130%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Arich Enterprise Co Ltd (4173)?
The net margin of Arich Enterprise Co Ltd is 3.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Arich Enterprise Co Ltd (4173)?
The return on equity (ROE) of Arich Enterprise Co Ltd is 3.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Arich Enterprise Co Ltd (4173)?
On an EBIT basis the return on assets of Arich Enterprise Co Ltd is 1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Arich Enterprise Co Ltd (4173)?
The operating margin of Arich Enterprise Co Ltd is 4.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Arich Enterprise Co Ltd (4173)?
Revenue at Arich Enterprise Co Ltd is growing −0.7% versus a year earlier (3y avg +15.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Arich Enterprise Co Ltd (4173)?
Earnings per share at Arich Enterprise Co Ltd are growing −60.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Arich Enterprise Co Ltd (4173) generate?
The free cash flow of Arich Enterprise Co Ltd is −1.9B TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Arich Enterprise Co Ltd (4173) hold?
Arich Enterprise Co Ltd holds more cash than debt, 225M TWD net (fiscal year 2023). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Arich Enterprise Co Ltd in the live analysis
One click puts Arich Enterprise Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 4, 2026